bioAffinity Technologies, Inc. (BIAF) — Strategic Asset Allocation Index
bioAffinity Technologies, Inc. (BIAF) has a Strategic Asset Allocation Index of 0.0% as of September 2022. Strategic assets (PP&E of $1.78K plus long-term investments of $-) total $1.78K, measured against net assets of $12.60 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BIAF net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for bioAffinity Technologies, Inc. (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for bioAffinity Technologies, Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See BIAF net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|